论文信息 - Effect of secukinumab on the clinical activity and disease burden of nail psoriasis: 32‐week results from the randomized placebo‐controlled TRANSFIGURE trial - 字舞流文

Effect of secukinumab on the clinical activity and disease burden of nail psoriasis: 32‐week results from the randomized placebo‐controlled TRANSFIGURE trial

K. Reich | M. Augustin | U. Mrowietz | P. Arenberger | J. Sullivan | M. Milutinovic | A. Parneix | S. Jazayeri | R. You | P. Regnault | M. Augustin | U. Mrowietz